Szela Mary T
SEC insider (Form 3/4/5 filer). CIK 0001410289. CEO and President at TriSalus Life Sciences, Inc. (TLSI) and 3 other issuers. 28 reported Form 4/5 transactions since Sep 2024; latest on Oct 5, 2026. Located in WESTMINSTER, CO.
Companies Szela Mary T has filed insider reports for
- TriSalus Life Sciences, Inc. (TLSI): Director, Officer, CEO and President
- Absci Corp (ABSI): Director
- Kura Oncology, Inc. (KURA): Director
- Averin Capital Acquisition Corp. (ACAAU): Director
Szela Mary T
CIK: 0001410289
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (28 total)
- Oct 5, 2026TLSI
TriSalus Life Sciences, Inc.
Tax PaymentDirect2.7K shares at avg. $4.38$12K - Jun 30, 2026ABSI
Absci Corp
PurchaseDirect12.9K shares at avg. $11.54$149K - Jun 30, 2026TLSI
TriSalus Life Sciences, Inc.
AwardDirect4K shares at avg. $3.87$15K - Jun 4, 2026ABSI
Absci Corp
AwardDirect8.4K shares- - Jun 4, 2026ABSI
Absci Corp
AwardDirect10.1K shares- - Jun 4, 2026KURA
Kura Oncology, Inc.
AwardDirectOption to purchase common stock
35K shares- - May 15, 2026TLSI
TriSalus Life Sciences, Inc.
PurchaseDirect39.7K shares at avg. $2.59$103K - Mar 17, 2026TLSI
TriSalus Life Sciences, Inc.
SaleDirect15.9K shares at avg. $3.85$61K - Mar 11, 2026TLSI
TriSalus Life Sciences, Inc.
SaleDirect4.4K shares at avg. $4.13$18K - Feb 23, 2026TLSI
TriSalus Life Sciences, Inc.
PurchaseDirect30.5K shares at avg. $4.10$125K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 5, 2026 |  TLSI TriSalus Life Sciences, Inc. | Tax Payment | 2,693 | $4.38 | $11,795 | Direct |
| Jun 30, 2026 |  ABSI Absci Corp | Purchase | 12,900 | $11.54 | $148,866 | Direct |
| Jun 30, 2026 | TLSI TriSalus Life Sciences, Inc. | Award | 3,990 | $3.87 | $15,441 | Direct |
| Jun 4, 2026 | ABSI Absci Corp | Award | 8,400 | - | $0 | Direct |
| Jun 4, 2026 | ABSI Absci Corp | Award | 10,100 | - | $0 | Direct |
| Jun 4, 2026 |  KURA Kura Oncology, Inc. | Award Option to purchase common stock | 35,000 | - | - | Direct |
| May 15, 2026 | TLSI TriSalus Life Sciences, Inc. | Purchase | 39,682 | $2.59 | $102,776 | Direct |
| Mar 17, 2026 | TLSI TriSalus Life Sciences, Inc. | Sale | 15,944 | $3.85 | $61,384 | Direct |
| Mar 11, 2026 | TLSI TriSalus Life Sciences, Inc. | Sale | 4,358 | $4.13 | $17,999 | Direct |
| Feb 23, 2026 | TLSI TriSalus Life Sciences, Inc. | Purchase | 30,487 | $4.10 | $124,997 | Direct |
1-10 of 28 transactions